Product Code: ETC6190588 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia Scabies Treatment Market is expected to grow due to the rising prevalence of scabies, a highly contagious skin condition caused by mites. The market is driven by the increasing awareness and availability of over-the-counter and prescription treatments. Topical treatments, such as permethrin creams and oral medications, remain popular for managing scabies, though newer therapies with fewer side effects are emerging in response to consumer demand for safer options. Healthcare providers continue to raise awareness about the importance of early diagnosis and treatment to prevent outbreaks, particularly in close-contact environments like schools and healthcare facilities. Additionally, with the increasing number of international travelers, the market for scabies treatment is also affected by global travel trends.
Australias scabies treatment market is shaped by recurring outbreaks in certain demographics and regions, particularly in rural and indigenous communities. Public health initiatives are increasingly emphasizing early detection and community-wide treatment approaches. Theres growing use of topical agents, along with a push for simplified oral medications that improve compliance. Innovations are focusing on reducing treatment times and minimizing irritation, especially in pediatric and sensitive populations. Awareness campaigns by healthcare providers are helping to destigmatize the condition and encourage prompt treatment. Remote healthcare delivery, including telemedicine consultations and mobile clinics, is also enhancing accessibility to treatment.
The Australia scabies treatment market faces challenges related to patient awareness, treatment efficacy, and regulatory constraints. Scabies, a highly contagious skin condition caused by mites, often goes undiagnosed due to its similarity to other skin conditions, which can lead to delays in treatment and further spread of the disease. Despite available treatments, the challenge of ensuring the efficacy and safety of these products remains significant, especially in light of increasing resistance to certain drugs. Moreover, regulatory bodies like the Therapeutic Goods Administration (TGA) impose strict standards on the approval and marketing of treatments, which can limit the availability of new or alternative therapies. Public education campaigns are also essential in ensuring early diagnosis and timely treatment to prevent outbreaks, but achieving this awareness on a larger scale presents a substantial challenge in the market.
The scabies treatment market in Australia is expanding due to increased awareness of the condition and growing demand for effective topical therapies. Scabies outbreaks in schools, nursing homes, and healthcare facilities drive demand for prescription and over-the-counter treatments. Australian dermatology clinics and pharmacies are the primary distribution channels for scabies medications, which include permethrin creams, oral ivermectin, and newer drug classes. The market is also witnessing increased interest in combination treatments that target both scabies mites and secondary skin infections. With Australias aging population, demand for scabies treatments in geriatric and institutional settings is expected to rise. Investors can look into companies involved in developing new topical treatments, research on scabies resistance, and innovations in delivery systems. Partnerships with healthcare providers and pharmacies can help scale market reach.
The Australian government addresses scabies as a public health concern, particularly in Indigenous and remote communities where prevalence is higher. Treatments such as permethrin and ivermectin are approved by the TGA, ensuring they meet national safety and efficacy standards. The government supports community-wide treatment programs, especially in outbreak situations, through coordination with state health departments. Educational outreach and early intervention strategies are implemented to promote awareness and timely treatment. Policies also focus on reducing overcrowding and improving hygiene infrastructure, which are key factors in preventing transmission. These measures reflect a holistic approach to managing and reducing the burden of scabies in Australia.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Scabies Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Scabies Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Scabies Treatment Market - Industry Life Cycle |
3.4 Australia Scabies Treatment Market - Porter's Five Forces |
3.5 Australia Scabies Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Scabies Treatment Market Revenues & Volume Share, By Prescription Medication, 2021 & 2031F |
3.7 Australia Scabies Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Scabies Treatment Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Australia Scabies Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Scabies Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Scabies Treatment Market Trends |
6 Australia Scabies Treatment Market, By Types |
6.1 Australia Scabies Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Scabies Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Scabies Treatment Market Revenues & Volume, By Typical Scabies, 2021- 2031F |
6.1.4 Australia Scabies Treatment Market Revenues & Volume, By Nodular Scabies, 2021- 2031F |
6.1.5 Australia Scabies Treatment Market Revenues & Volume, By Norwegian Scabies, 2021- 2031F |
6.2 Australia Scabies Treatment Market, By Prescription Medication |
6.2.1 Overview and Analysis |
6.2.2 Australia Scabies Treatment Market Revenues & Volume, By Elimite, 2021- 2031F |
6.2.3 Australia Scabies Treatment Market Revenues & Volume, By Lindane, 2021- 2031F |
6.2.4 Australia Scabies Treatment Market Revenues & Volume, By Eurax, 2021- 2031F |
6.2.5 Australia Scabies Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Scabies Treatment Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Scabies Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Australia Scabies Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Australia Scabies Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Scabies Treatment Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Australia Scabies Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Scabies Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Australia Scabies Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Australia Scabies Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Australia Scabies Treatment Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Australia Scabies Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Australia Scabies Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Australia Scabies Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 Australia Scabies Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Scabies Treatment Market Import-Export Trade Statistics |
7.1 Australia Scabies Treatment Market Export to Major Countries |
7.2 Australia Scabies Treatment Market Imports from Major Countries |
8 Australia Scabies Treatment Market Key Performance Indicators |
9 Australia Scabies Treatment Market - Opportunity Assessment |
9.1 Australia Scabies Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Scabies Treatment Market Opportunity Assessment, By Prescription Medication, 2021 & 2031F |
9.3 Australia Scabies Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Scabies Treatment Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.5 Australia Scabies Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Scabies Treatment Market - Competitive Landscape |
10.1 Australia Scabies Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Scabies Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |